Prevalence of TB among the study participants, July—September 2016, South Africa.

<p>Prevalence of TB among the study participants, July—September 2016, South Africa.</p

Preferred method of response to the survey among study participants, July—September 2016, South Africa (N = 459).

<p>Preferred method of response to the survey among study participants, July—September 2016, South Africa (N = 459).</p

Characteristics of the study participants, July—September 2016, South Africa.

<p>Characteristics of the study participants, July—September 2016, South Africa.</p

Monthly observed deaths, predicted deaths and predicted baseline (Poisson model), South Africa, 1999–2009.

<p><b>A:</b> Pulmonary tuberculosis deaths in individuals <65 years of age. <b>B:</b> Pulmonary tuberculosis deaths in individuals ≥65 years of age; <b>C</b> Non-tuberculosis respiratory deaths in individuals <65 years of age. <b>D</b> Non-tuberculosis respiratory deaths in individuals ≥65 years of age.</p

Monthly detection rate (i.e., monthly number of positive specimens divided by total specimens) of influenza (all ages) in South Africa, 1999–2009.

<p>Monthly detection rate (i.e., monthly number of positive specimens divided by total specimens) of influenza (all ages) in South Africa, 1999–2009.</p

Population incidence of cryptococcal, tuberculous and pneumococcal meningitis among adults in Gauteng province, South Africa, showing key treatment interventions, 2009–2012 (n = 11,531).

<p>PCV-7 = seven-valent pneumococcal conjugate vaccine introduction. PCV-13 = thirteen-valent pneumococcal conjugate vaccine introduction. GeneXpert = GeneXpert MTB/Rif assay introduction. CrAg screening = introduction of cryptococcal antigen screening and treatment intervention.</p

Number and percentage of major pathogenic organisms isolated from all CSF specimens tested, as recorded in the NHLS CDW, in Gauteng province, South Africa, by year 2009 through 2012 (n = 11,891).

<p>Number and percentage of major pathogenic organisms isolated from all CSF specimens tested, as recorded in the NHLS CDW, in Gauteng province, South Africa, by year 2009 through 2012 (n = 11,891).</p

Demographic characteristics of patients with laboratory-confirmed fungal and bacterial meningitis in Gauteng province, South Africa, 2009 through 2012 (n = 11,891).

<p>Demographic characteristics of patients with laboratory-confirmed fungal and bacterial meningitis in Gauteng province, South Africa, 2009 through 2012 (n = 11,891).</p

Incidence of cryptococcal meningitis and pneumococcal meningitis, by age group and gender, 2012.

<p>CM = cryptococcal meningitis, PM = pneumococcal meningitis.</p